Because insulin resistance and liver disease progression are highly related (13), we confirmed the increased expression of several markers of metabolically associated steatohepatitis (MASH) development in Adn-Lpin1–/– mice by quantitative reverse transcriptase PCR. Here, LPIN1 is linked to metabolic dysfunction-associated steatohepatitis.